服务电话(移):17319309550
≥98% (HPLC)
NA.77
DMSO: 20 mg/mL, clear
XMD17-109 is a cell-permeable, non-cytotoxic ATP site-targeting pyrimido-diazepinone derivative that acts as potent inhibitor against ERK5 (MAPK7, BMK1) kinase activity in cell-free assay (IC₅₀ = 162 nM; [ATP] = 50 μM) and EGF-induced ERK5 autophosphorylation in HeLa cells (IC₅₀ = 90 nM). XMD17-109 displayed excellent target selectivity on a 442-kinase panel. XMD17-109 effectively inhibits inflammatory stimuli-induced IL-6 and IL-8 production from human endothelial cells in vitro and protects mice from LPS-induced mortality and systemic inflammation & coagulopathy in vivo with good pharmacokinetics.
好评度 | 商品满意度 | 服务满意度 | 发货满意度 |
"SML1753-5MG,XMD17-109"商品可能已被商家删除,您可查看其他相似商品!
相似产品推荐